Skip to main content
Top
Published in: Trials 1/2021

01-12-2021 | Care | Study protocol

A multicenter cluster randomized, stepped wedge implementation trial for targeted normoxia in critically ill trauma patients: study protocol and statistical analysis plan for the Strategy to Avoid Excessive Oxygen (SAVE-O2) trial

Authors: Layne Dylla, David J. Douin, Erin L. Anderson, John D. Rice, Conner L. Jackson, Vikhyat S. Bebarta, Christopher J. Lindsell, Alex C. Cheng, Steven G. Schauer, Adit A. Ginde

Published in: Trials | Issue 1/2021

Login to get access

Abstract

Background

Targeted normoxia (SpO2 90–96% or PaO2 60–100 mmHg) may help to conserve oxygen and improve outcomes in critically ill patients by avoiding potentially harmful hyperoxia. However, the role of normoxia for critically ill trauma patients remains uncertain. The objective of this study is to describe the study protocol and statistical analysis plan for the Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2) clinical trial.

Methods

Design, setting, and participants: Protocol for a multicenter cluster randomized, stepped wedge implementation trial evaluating the effectiveness of a multimodal intervention to target normoxia in critically ill trauma patients at eight level 1 trauma centers in the USA. Each hospital will contribute pre-implementation (control) and post-implementation (intervention) data. All sites will begin in the control phase with usual care. When sites reach their randomly assigned time to transition, there will be a one-month training period, which does not contribute to data collection. Following the 1-month training period, the site will remain in the intervention phase for the duration of the trial.
Main outcome measures: The primary outcome will be supplemental oxygen-free days, defined as the number of days alive and not on supplemental oxygen. Secondary outcomes include in-hospital mortality to day 90, hospital-free days to day 90, ventilator-free days (VFD) to day 28, time to room air, Glasgow Outcome Score (GOS), and duration of time receiving supplemental oxygen.

Discussion

SAVE-O2 will determine if a multimodal intervention to improve compliance with targeted normoxia will safely reduce the need for concentrated oxygen for critically injured trauma patients. These data will inform military stakeholders regarding oxygen requirements for critically injured warfighters, while reducing logistical burden in prolonged combat casualty care.

Trial registration

ClinicalTrials.​govNCT04534959. Registered September 1, 2020.
Appendix
Available only for authorised users
Literature
8.
go back to reference Douin DJ, Schauer SG, Anderson EL, Jones J, DeSanto K, Cunningham C, et al. Systematic Review of Oxygenation and Clinical Outcomes to Inform Oxygen Targets in Critically Ill Trauma Patients. J Trauma Acute Care Surg. 2019;87(4):961–77.CrossRefPubMed Douin DJ, Schauer SG, Anderson EL, Jones J, DeSanto K, Cunningham C, et al. Systematic Review of Oxygenation and Clinical Outcomes to Inform Oxygen Targets in Critically Ill Trauma Patients. J Trauma Acute Care Surg. 2019;87(4):961–77.CrossRefPubMed
12.
go back to reference Mackle DM, Bailey MJ, Beasley RW, Bellomo R, Bennett VL, Deane AM, et al. Protocol summary and statistical analysis plan for the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX). Crit Care Resusc. 2018;20(1):22–32.PubMed Mackle DM, Bailey MJ, Beasley RW, Bellomo R, Bennett VL, Deane AM, et al. Protocol summary and statistical analysis plan for the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX). Crit Care Resusc. 2018;20(1):22–32.PubMed
Metadata
Title
A multicenter cluster randomized, stepped wedge implementation trial for targeted normoxia in critically ill trauma patients: study protocol and statistical analysis plan for the Strategy to Avoid Excessive Oxygen (SAVE-O2) trial
Authors
Layne Dylla
David J. Douin
Erin L. Anderson
John D. Rice
Conner L. Jackson
Vikhyat S. Bebarta
Christopher J. Lindsell
Alex C. Cheng
Steven G. Schauer
Adit A. Ginde
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Care
Published in
Trials / Issue 1/2021
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-021-05688-6

Other articles of this Issue 1/2021

Trials 1/2021 Go to the issue